Background: Two important virulence factors, urease and cagA, play an important role in Helicobacter pylori (H. pylori) gastric cancer. Aim of this study was to investigate the expression level and function of ureB and cagA using small interfering RNAs (siRNA).
Methods: SS1 strain of H. pylori was considered as host for natural transformation. siRNA designed for ureB and cagA genes were inserted in pGPU6/GFP/Neo siRNA plasmid vector to evaluate using phenotypic and genotypic approaches. Then, qPCR was performed for determining inhibition rate of ureB and cagA gene expression.
Results: The expression levels of siRNA-ureB and siRNA-cagA in the recombinant strain SS1 were reduced by about 5000 and 1000 fold, respectively, compared to the native H. pylori strain SS1. Also, preliminary evaluation of siRNA-ureB in vitro showed inhibition of urea enzyme activity. These data suggest that siRNA may be a powerful new tool for gene silencing in vitro, and for the development of RNAi-based anti-H. pylori therapies.
Conclusion: Our results show that targeting ureB and cagA genes with siRNA seems to be a new strategy to inhibit urease enzyme activity, reduce inflammation and colonization rate.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10729366 | PMC |
| http://dx.doi.org/10.1186/s12866-023-03143-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preliminary investigation of the anti- activity of Triphala.
Front Pharmacol
November 2024
School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong, China.
Article Synopsis
- Triphala is a combination of three botanical drugs known for its heat-clearing, anti-inflammatory, antioxidant, and antibacterial properties, extensively used in India and Tibet.
- The study examines the antibacterial effects of Triphala on various bacteria strains using different methods, revealing its capability to inhibit bacterial growth and biofilm formation.
- Results indicate that Triphala disrupts bacterial structure and downregulates key genes, highlighting its potential as a new therapeutic option for preventing and treating bacterial infections.
Candidate Antigens and the Development of Helicobacter pylori Vaccines.
Helicobacter
August 2024
Research and Development Centre, Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd., Beijing, China.
Background: Infection with Helicobacter pylori (Hp) mostly occurs during childhood, and persistent infection may lead to severe gastric diseases and even gastric cancer. Currently, the primary method for eradicating Hp is through antibiotic treatment. However, the increasing multidrug resistance in Hp strains has diminished the effectiveness of antibiotic treatments.
View Article and Find Full Text PDFOuter membrane vesicles from genetically engineered serovar Typhimurium presenting antigens UreB and CagA induce protection against infection in mice.
Virulence
December 2024
The First Affiliated Hospital, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University.
Article Synopsis
- The text discusses the link between globally prevalent infections and chronic gastritis, potentially leading to gastric cancer, prompting the need for improved vaccine strategies due to rising antibiotic resistance.
- Researchers explored using outer membrane vesicles (OMVs) from a specific bacterial strain as a platform to deliver multiple antigens, unlike current single-antigen vaccines.
- The study engineered three key antigens and found that co-delivering specific combinations significantly enhanced immune responses in mice, suggesting OMVs as a promising vector for developing more effective vaccines against these infections.
Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection.
BMC Infect Dis
June 2024
Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Background: Refractory Helicobacter pylori (H. pylori) infection inevitably increase the difficulty of drug selection. Here, we described our experience with the use of a novel tetravalent IgY against H.
View Article and Find Full Text PDFRapid and multi-target genotyping of Helicobacter pylori with digital microfluidics.
Biosens Bioelectron
July 2024
Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, 563006, China; College of Laboratory Medicine, Zunyi Medical University, Zunyi, 563000, China. Electronic address:
Helicobacter pylori (H. pylori) infection correlates closely with gastric diseases such as gastritis, ulcers, and cancer, influencing more than half of the world's population. Establishing a rapid, precise, and automated platform for H.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!